Fludeoxyglucose (F-18) 232 Gbq Solution is a Health Canada–registered radiopharmaceutical drug (DIN 02462354) held by Lawson Health Research Institute, containing Fludeoxyglucose 18f. Health Canada lists its status as Marketed (status date 17 Oct 2018). Nexara Health has matched 25 registrations of Fludeoxyglucose 18f across 6 other regulated markets.
Health Canada registration
| DIN | 02462354 |
|---|---|
| Brand name | Fludeoxyglucose (F-18) |
| Active ingredient | Fludeoxyglucose 18f |
| Strength | 232 Gbq |
| Dosage form | Solution |
| Route | Intravenous |
| Company | Lawson Health Research Institute |
| Status | Marketed — 17 Oct 2018 |
| Class | Radiopharmaceutical |
| ATC | V09IX04 FLUDEOXYGLUCOSE (18F) |
| AHFS | 36:68.00 ; 78:00.00 |
| Regulator record | Health Canada DPD entry · Product monograph |
Fludeoxyglucose 18f registered in other markets
25 registrations of the same molecule in 6 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Bulgaria | (18f) Fdg/Biokosmos | Biokosmos S.a. | 44-6937 MBq/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Bulrad 18f-Fdg | Българска Радиофармацевтична Компания ООД | 250 MBq/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Fludeoxyglucose (18F) GE Healthcare | GE Healthcare B.V. | 250 MBq/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Fludeoxyglucose (18F) Monrol | Monrol Europe SRL. | 200-2200 MBq/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Czech Republic | (18f)Fdg-Fr | — | 300-3100MBQ/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | 2-[18f]-Fdg | — | 1-20GBQ | Inj Sol | R | SUKL DLP |
| Czech Republic | Fludeoxyglucose (18f) Biont | — | 200-2200MBQ/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Fludeoxyglucose (18f) Ujv | — | 100-1500MBQ/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Fludeoxyglukosa | — | 100-1500MBQ/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Glunektik | — | 1GBQ/ML | Inj Sol | R | SUKL DLP |
| Denmark | FluCore | Herlev Hospital, University CPH Department of Nuclear Medicine | injektionsvæske, opløsning | National | Laegemiddelstyrelsen | |
| Denmark | Fludeoxyglucose "OUH" | Odense Universitetshospital, Nuklearmedicinsk afdeling | 400 MBq-316 GBq/htgl | injektionsvæske, opløsning | National | Laegemiddelstyrelsen |
| Denmark | Fludeoxyglucose (F-18) "Risø" | Hevesy Laboratoriet, DTU Sundhedsteknologi, Danmarks Tekniske Universitet | 400 MBq - 90 GBq | injektionsvæske | National | Laegemiddelstyrelsen |
| Denmark | Fluor-18-FDG | Rigshospitalet | injektionsvæske | National | Laegemiddelstyrelsen | |
| Denmark | PCA (18F) Fludeoxyglucose | Aarhus Universitetshospital, Nuklearmedicin og PET | injektionsvæske, i.v. | National | Laegemiddelstyrelsen | |
| Ireland | ERtracER Solution for Injection | Curium Pharma Ireland Limited | Solution for injection | Marketed | HPRA | |
| Netherlands | [18F]FDG Alliance Medical 300-3100 MBq/ml oplossing voor injectie | Alliance Medical RP Berlin GmbH | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | 18F-FDG Hoboken 250 MBq/ml, oplossing voor injectie | Cyclotron Rotterdam B.V. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Fludeoxyglucose (18F) CNW 100 - 400 MBq, oplossing voor injectie in een voorgevulde spuit | Cyclotron Noordwest B.V. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Fludeoxyglucose (18F) Curium-international, 185 MBq/ml oplossing voor injectie | Curium International | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Fludeoxyglucose (18F) RTM 200 MBq/ml, oplossing voor injectie | Radboud Translational Medicine B.V. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | GlucoPET 250 MBq/ml, oplossing voor injectie | GE Healthcare B.V. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Glucotrace, oplossing voor injectie 185 MBq/ml | Curium PET Liege | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Steripet 250 MBq/ml, oplossing voor injectie | GE Healthcare B.V. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| South Africa | Gluscan | NTP Radioisotopes (Pty) Ltd | 600 MBq/mL | Inj | S4 | DoH SEP database |
See every manufacturer of Fludeoxyglucose 18f worldwide →
Regulator price references for Fludeoxyglucose 18f
Published list or reimbursement prices for Fludeoxyglucose 18f presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| South Africa | Gluscan | 1 | 9,305.01 ZAR | single exit price | DoH SEP database | 2026-09-01 |
Marketed Canadian products with the same active ingredient
| DIN | Product | Company | Strength | Form |
|---|---|---|---|---|
| 02433230 | Fludeoxyglucose (18f) Injection | Bc Cancer, Part Of The Provincial Health Services Authority | 0.5 Gbq | Solution |
| 02412837 | Fludeoxyglucose (18f) Injection | Shared Health | 0.5 Gbq / 16 mL | Solution |
Related molecules (ATC V09IX)
- Fludeoxyglucose 18f
- GALLIUM (68Ga) GOZETOTIDE
- GALLIUM 68 Ga CHLORIDE
- Iobenguane 123 I
- Sodium Fluoride F 18
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Fludeoxyglucose (F-18) (DIN 02462354) marketed in Canada?
Yes. Health Canada lists DIN 02462354 as Marketed as of 17 Oct 2018.
Who holds the Canadian licence for this product?
Lawson Health Research Institute is the company of record in the Health Canada Drug Product Database.
Is Fludeoxyglucose 18f registered outside Canada?
Yes — Nexara Health has matched 25 registrations in 6 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02462354, status date 2018-10-17; national medicine registries: BDA, DoH SEP database, EU national register, HPRA, Laegemiddelstyrelsen, SUKL DLP; price sources: DoH SEP database. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02462354, status date 2018-10-17; national medicine registries: BDA, DoH SEP database, EU national register, HPRA, Laegemiddelstyrelsen, SUKL DLP; price sources: DoH SEP database.
Health Canada Drug Product Database (DPD), DIN 02462354, status date 2018-10-17; national medicine registries: BDA, DoH SEP database, EU national register, HPRA, Laegemiddelstyrelsen, SUKL DLP; price sources: DoH SEP database. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.